Literature DB >> 15118009

Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias.

Vu H Nguyen, H Jeffrey Lawrence.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118009     DOI: 10.1200/JCO.2004.99.298

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

1.  Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.

Authors:  Shivani S Shinde; Drew Seisler; Gamini Soori; Pamela J Atherton; Deirdre R Pachman; Jacqueline Lafky; Kathryn J Ruddy; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2015-07-09       Impact factor: 3.603

Review 2.  An update on drug-induced arthritis.

Authors:  Marwan H Adwan
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

3.  Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.

Authors:  Brandi N Reeves; Shaker R Dakhil; Jeff A Sloan; Sherry L Wolf; Kelli N Burger; Arif Kamal; Nguyet A Le-Lindqwister; Gamini S Soori; Anthony J Jaslowski; Joseph Kelaghan; Paul J Novotny; Daniel H Lachance; Charles L Loprinzi
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

4.  Proposed medications for taxane-induced myalgia and arthralgia (Review).

Authors:  Atsushi Imai; Kazutoshi Matsunami; Hiroshi Takagi; Satoshi Ichigo
Journal:  Oncol Lett       Date:  2012-03-23       Impact factor: 2.967

Review 5.  Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy-a systematic review.

Authors:  Ricardo Fernandes; Sasha Mazzarello; Habeeb Majeed; Stephanie Smith; Risa Shorr; Brian Hutton; Mohammed Fk Ibrahim; Carmel Jacobs; Michael Ong; Mark Clemons
Journal:  Support Care Cancer       Date:  2015-09-19       Impact factor: 3.603

Review 6.  Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.

Authors:  Ricardo Fernandes; Sasha Mazzarello; Brian Hutton; Risa Shorr; Habeeb Majeed; Mohammed Fk Ibrahim; Carmel Jacobs; Michael Ong; Mark Clemons
Journal:  Support Care Cancer       Date:  2016-05-05       Impact factor: 3.603

Review 7.  Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).

Authors:  Yaqin Han; Maree T Smith
Journal:  Front Pharmacol       Date:  2013-12-18       Impact factor: 5.810

8.  Docetaxel-associated myalgia-arthralgia syndrome in patients with breast cancer.

Authors:  Chelsea Seguin; Natalie Kovacevich; Ioannis A Voutsadakis
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-01-23

9.  Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis.

Authors:  Yoshitaka Saito; Yoh Takekuma; Masaki Kobayashi; Tatsuhiko Sakamoto; Hiroko Yamashita; Mitsuru Sugawara
Journal:  Support Care Cancer       Date:  2021-07-06       Impact factor: 3.603

Review 10.  Peripheral neuropathy caused by Paclitaxel and docetaxel: an evaluation and comparison of symptoms.

Authors:  Cindy Tofthagen; R Denise McAllister; Constance Visovsky
Journal:  J Adv Pract Oncol       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.